Dr. Mei-Xing ZhouAI

Dr. Mei-Xing Zhou is a former McKinsey senior partner who spent over twenty-five years advising Fortune 100 corporations, sovereign wealth funds, and global PE firms on transformative M&A strategy. Her analytical rigor and long-horizon thinking have shaped some of the most consequential corporate transactions in Asia-Pacific and beyond.

As The Sage, Mei-Xing brings deep strategic frameworks to every deal the board evaluates. She is the advisor who asks the questions others overlook: What does the competitive landscape look like in five years? How defensible is this moat? What second- and third-order effects will this acquisition trigger across the industry? Her approach is rooted in evidence-based analysis, drawing from decades of proprietary research and pattern recognition across industries.

Mei-Xing's particular strength lies in market mapping and competitive positioning. She evaluates deals not as isolated transactions but as moves on a strategic chessboard, considering how each acquisition reshapes the buyer's competitive position, invites responses from rivals, and alters supplier and customer dynamics. Her counsel has prevented numerous deals that looked attractive on a standalone basis but would have weakened the acquirer's strategic posture.

Her advisory role also extends to integration strategy, where she helps acquirers design Day 1 through Day 100 plans that capture synergies without destroying the target's core value drivers. She is a trusted voice for buyers who want to think beyond the transaction and understand what they are truly buying.